Congenital Heart Innovation Report


Congenital Heart Center 2020 Innovation Report

Quality & Patient Safety Initiatives

NewYork-Presbyterian’s Congenital Heart Disease Program has helped to found and lead many of the national leading quality registries, helping to improve patient outcomes through funded research and team-based clinical care.

Committed to improving outcomes, NewYork-Presbyterian’s Congenital Heart Disease Program tracks and reports outcomes to multiple clinical registries, including the STS database and the IMPACT Registry, as well as C3PO and CCISC registries that are focused on improving outcomes after pediatric and congenital cardiac catheterization. Our emphasis on tracking and publicly reporting outcomes means increased transparency and improved quality and safety measures for patients.

As director of Outcomes and Quality for the Congenital Heart Center, pediatric cardiologist Dr. Brett R. Anderson leads ongoing efforts directed at quality assessment and quality improvement. At monthly multidisciplinary risk-adjusted mortality and morbidity conferences, data is reviewed on each patient. Additionally, surgeon- and interventional cardiologist- specific mortality and complication data are reviewed monthly, including postoperative infections, cardiac arrest, reoperations, readmissions, and neurological changes. Performance metrics are disseminated bi-annually, enabling the team to identify and correct potential issues early, ultimately leading to improved patient safety and outcomes.

Quality initiatives to dramatically reduce radiation doses for infants, children, and young adults undergoing electrophysiology or interventional catherization procedures have been spearheaded by Dr. Leonardo Liberman and Dr. Matthew A. Crystal.

Our team has helped to found and lead many of the national leading quality registries, helping to improve patient outcomes through funded research and team-based clinical care, including:

  • The STS Congenital Heart Surgery Database (STS-CHSD) — Dr. Bacha has served as an STS Board member; Drs. Bacha and Anderson now serve on the STS-CHSD Task Force to improve public reporting
  • The IMPACT Registry — Dr. Holzer has led many of the interventional registry efforts and has been a member of the IMPACT Registry Steering Committee. Currently, Dr. Holzer chairs the IMPACT Registry Research and Publications Committee and is an active member of the IMPACT registry steering committee
  • Congenital Cardiac Catheterization Project on Outcomes (C3PO) — Dr. Holzer chairs the research and publications committee of the C3PO collaborative
  • The Pediatric Cardiac Critical Care Consortium (PC4) — Dr. Eva Cheung and Dr. Kelly Haque serve as a physician leads
  • The Pediatric Acute Care Cardiology (PAC3) — Dr. Anne Ferris serves as a physician lead
  • The Pediatric Heart Transplant Society (PHTS) — Dr. Linda J. Addonizio was a founder of the society in 1993, Dr. Marc E. Richmond is a past president, and Dr. Warren A. Zuckerman is currently the chair of the society’s Scientific Committee
  • The New York State Congenital Heart Surgery Collaborative for Longitudinal Outcomes and Utilization of Resources (CHS-COLOUR), which was founded by Dr. Anderson in 2018, aims to improve outcomes and reduce health inequities for children with CHD in New York State
  • ACPC Quality Network (QNet) — Dr. Holzer serves as the physician lead